Literature DB >> 24019446

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.

Robert S Rosenson1, H Bryan Brewer, Benjamin Ansell, Philip Barter, M John Chapman, Jay W Heinecke, Anatol Kontush, Alan R Tall, Nancy R Webb.   

Abstract

Keywords:  atherosclerosis; cardiovascular diseases; inflammation; lipids; lipoproteins

Mesh：

Substances：

Year:  2013        PMID： 24019446     DOI： 10.1161/CIRCULATIONAHA.113.000962

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  69 in total

1.  HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Authors:  Benjamin Emert; Yehudit Hasin-Brumshtein; James R Springstead; Ladan Vakili; Judith A Berliner; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

2.  Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.

Authors:  Jia Teng Sun; Yuan Yuan Chen; Jing Yan Mao; Yan Ping Wang; Ya Fen Chen; Xiang Hu; Ke Yang; Yan Liu
Journal:  J Cardiovasc Transl Res       Date:  2019-07-31       Impact factor: 4.132

3.  Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men.

Authors:  Katya B Rubinow; Tomas Vaisar; Jing H Chao; Jay W Heinecke; Stephanie T Page
Journal:  J Clin Lipidol       Date:  2018-04-30       Impact factor: 4.766

4.  Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.

Authors:  Michael B Fessler
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

Review 5.  HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.

Authors:  Robert S Rosenson; H Bryan Brewer; Philip J Barter; Johan L M Björkegren; M John Chapman; Daniel Gaudet; Daniel Seung Kim; Eric Niesor; Kerry-Anne Rye; Frank M Sacks; Jean-Claude Tardif; Robert A Hegele
Journal:  Nat Rev Cardiol       Date:  2017-08-10       Impact factor: 32.419

6.  Influence of HDL particles on cell-cholesterol efflux under various pathological conditions.

Authors:  Bela F Asztalos; Katalin V Horvath; Michael Mehan; Yuya Yokota; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2017-04-18       Impact factor: 5.922

Review 7.  Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.

Authors:  Russell M Medford; T Forcht Dagi; Robert S Rosenson; Margaret K Offermann
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

Review 8.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 9.  Role of HDL in those with diabetes.

Authors:  Carlos G Santos-Gallego; Robert S Rosenson
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

10.  Response to letter regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy".

Authors:  Samia Mora; Robert J Glynn; Paul M Ridker
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.